FDA Approves Accrufer (ferric maltol) for the Treatment of Iron Deficiency in Adults

FDA Approves Accrufer (ferric maltol) for the Treatment of Iron Deficiency in Adults Print this page London, UK, 26 July 2019: Shield Therapeutics plc (LSE: STX), a commercial stage, pharmaceutical company with a focus on addressing iron deficiency, announces that the U.S. Food and Drug Administration (FDA) has approved its lead product Accrufer® (Feraccru® in… Read More »

Toussaint column: The closed-mouth secrets of American dentistry – Glenwood Springs Post Independent

Recently, I read a heartbreaking plea on a local Facebook group. A Glenwood Springs resident (I’ll call her Mary) asked for a dentist to volunteer to pull her husband’s tooth. It had been aching for six-plus months, causing fevers, nausea, fatigue and sleeplessness. I could have (tritely) posted back, “I feel his pain.” I was… Read More »

Headache treatment: The long journey to evidence-based guidelines – Healio

PHILADELPHIA — Headache treatment has come a long way to reach the current system of evidence-based guidelines, according to a presentation at the American Headache Society Annual Scientific Meeting. Stephen D. Silberstein, MD, FAHS, of the Jefferson Headache Center, described some of the earliest recorded treatments for headache, including an ancient Egyptian method that called… Read More »